Special considerations in mouse models of breast cancer

Breast Disease

Volumn 28, Issue , 2007, Pages 29-38

  Borowsky, Alexander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOM SYNDROME PROTEIN 1; BRCA1 PROTEIN; BRCA2 PROTEIN; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR BETA 2; PROTEIN P53; STEROID RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER MODEL; CANCER SUSCEPTIBILITY; COMPARATIVE ANATOMY; EXPERIMENTAL DESIGN; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ENGINEERING; GENOTYPE PHENOTYPE CORRELATION; KNOCKOUT MOUSE; MAMMARY GLAND; MOLECULAR MECHANICS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; REPRODUCIBILITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

EID: 36549043522     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-2007-28104     Document Type: Article

References (51)

1. A.D. Borowsky, Genetically engineering a mouse, Comparative medicine 53 (2003), 249-250.
2. C.W. Daniel, K.B. De Ome, J.T. Young, P.B. Blair and L.J. Faulkin, Jr., The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study, Proceedings of the National Academy of Sciences of the United States of America 61 (1968), 53-60.
3. R.D. Cardiff, H.A. Bern, L.J. Faulkin, C.W. Daniel, G.H. Smith, L.J. Young, D. Medina, M.B. Gardner, S.R. Wellings, G. Shyamala, R.C. Guzman, L. Rajkumar, J. Yang, G. Thordarson, S. Nandi, C.L. MacLeod, R.G. Oshima, A.K. Man, E.T. Sawai, J.P. Gregg, A.T. Cheung and D.H. Lau, Contributions of mouse biology to breast cancer research, Comparative medicine 52 (2002), 12-31.
4. S.W. Hayward, Y. Wang, M. Cao, Y.K. Hom, B. Zhang, G.D. Grossfeld, D. Sudilovsky and G.R. Cunha, Malignant transformation in a nontumorigenic human prostatic epithelial cell line, Cancer research 61 (2001), 8135-8142.
5. K.S. Aboody, A. Brown, N.G. Rainov, K.A. Bower, S. Liu, W. Yang, J.E. Small, U. Herrlinger, V. Ourednik, P.M. Black, X.O. Breakefield and E.Y. Snyder, Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas, Proceedings of the National Academy of Sciences of the United States of America 97 (2000), 12846-12851.
6. R.D. Cardiff, A. Rosner, M.A. Hogarth, J.J. Galvez, A.D. Borowsky and J.P. Gregg, Validation: The new challenge for pathology, Toxicologic pathology 32(Suppl 1) (2004), 31-39.
7. R.D. Cardiff, Mouse models of human breast cancer, Comparative medicine 53 (2003), 250-253.
8. R.D. Cardiff, M.R. Anver, B.A. Gusterson, L. Hennighausen, R.A. Jensen, M.J. Merino, S. Rehm, J. Russo, F.A. Tavassoli, L.M. Wakefield, J.M. Ward and J.E. Green, The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis meeting, Oncogene 19 (2000), 968-988.
9. A. Rosner, K. Miyoshi, E. Landesman-Bollag, X. Xu, D.C. Seldin, A.R. Moser, C.L. MacLeod, G. Shyamala, A.E. Gillgrass and R.D. Cardiff, Pathway pathology: Histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors, The American Journal of pathology 161 (2002), 1087-1097.
10. J. Jonkers and A. Berns, Conditional mouse models of sporadic cancer, Nature Reviews 2(2002), 251-265.
11. D. Medina, K.B. DeOme and L. Young, Tumor-producing capabilities of hyperplastic alveolar nodules in virgin and hormone-stimulated BALB/c f. C3H and C3Hf mice, J Natl Cancer Inst 44 (1970), 167-174.
12. D. Medina and K.B. DeOme, Carcinogen-induced mammary tumors from preneoplastic nodule outgrowths in BALB-c mice, Cancer Res 30 (1970), 1055-1059.
13. D. Medina and K.B. DeOme, Effects of various oncogenic agents on tumor-producing capabilities of series D BALB-c mammary nodule outgrowth lines, J Natl Cancer Inst 45 (1970), 353-363.
14. C.W. Daniel and L.J. Young, Influence of cell division on an aging process. Life span of mouse mammary epithelium during serial propagation in vivo, Experimental Cell Research 65 (1971), 27-32.
15. A.J. Alvi, H. Clayton, C. Joshi, T. Enver, A. Ashworth, M.M. Vivanco, T.C. Dale and M.J. Smalley, Functional and molecular characterisation of mammary side population cells, Breast Cancer Res 5 (2003), R1-R8.
16. M. Shackleton, F. Vaillant, K.J. Simpson, J. Stingl, G.K. Smyth, M.L. Asselin-Labat, L. Wu, G.J. Lindeman and J.E. Visvader, Generation of a functional mammary gland from a single stem cell, Nature 439 (2006), 84-88.
17. J. Ursini-Siegel, B. Schade, R.D. Cardiff and W.J. Muller, Insights from transgenic mouse models of ERBB2-induced breast cancer, Nature reviews 7 (2007), 389-397.
18. S.M. Dilworth, Polyoma virus middle T antigen and its role in identifying cancer-related molecules, Nature Reviews 2 (2002), 951-956.
19. R. Namba, L.J. Young, J.E. Maglione, E.T. McGoldrick, S. Liu, G.T. Wurz, M.W. DeGregorio, A.D. Borowsky, C.L. MacLeod, R.D. Cardiff and J.P. Gregg, Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ, Breast Cancer Res 7 (2005), R881-R889.
20. J.E. Maglione, D. Moghanaki, L.J. Young, C.K. Manner, L.G. Ellies, S.O. Joseph, B. Nicholson, R.D. Cardiff and C.L. MacLeod, Transgenic Polyoma middle-T mice model premalignant mammary disease, Cancer research 61 (2001), 8298-8305.
21. J.E. Maglione, E.T. McGoldrick, L.J. Young, R. Namba, J.P. Gregg, L. Liu, D. Moghanaki, L.G. Ellies, A.D. Borowsky, R.D. Cardiff and C.L. MacLeod, Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: Single origin, divergent evolution, and multiple outcomes, Molecular Cancer Therapeutics 3 (2004), 941-953.
22. R. Namba, J.E. Maglione, L.J. Young, A.D. Borowsky, R.D. Cardiff, C.L. MacLeod and J.P. Gregg, Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ, Mol Cancer Res 2 (2004), 453-463.
23. D.C. Sgroi, S. Teng, G. Robinson, R. LeVangie, J.R. Hudson, Jr. and A.G. Elkahloun, In vivo gene expression profile analysis of human breast cancer progression, Cancer Research 59 (1999), 5656-5661.
24. C.K. Abbey, A.D. Borowsky, E.T. McGoldrick, J.P. Gregg, J.E. Maglione, R.D. Cardiff and S.R. Cherry, In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia, Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 11438-11443.
25. C.K. Abbey, A.D. Borowsky, J.P. Gregg, R.D. Cardiff and S.R. Cherry, Preclinical imaging of mammary intraepithelial neoplasia with positron emission tomography, Journal of mammary gland biology and neoplasia 11 (2006), 137-149.
26. R. Namba, L.J. Young, C.K. Abbey, L. Kim, P. Damonte, A.D. Borowsky, J. Qi, C.G. Tepper, C.L. MacLeod, R.D. Cardiff and J.P. Gregg, Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ, Clin Cancer Res 12 (2006), 2613-2621.
27. D. Medina, F.S. Kittrell, A. Shepard, L.C. Stephens, C. Jiang, J. Lu, D.C. Allred, M. McCarthy and R.L. Ullrich, Biological and genetic properties of the p53 null preneoplastic mammary epithelium, Faseb J 16 (2002), 881-883.
28. I.G. Maroulakou, M. Anver, L. Garrett and J.E. Green, Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene, Proceedings of the National Academy of Sciences of the United States of America 91 (1994), 11236-11240.
29. V.L. Cressman, D.C. Backlund, E.M. Hicks, L.C. Gowen, V. Godfrey and B.H. Koller, Mammary tumor formation in p53- and BRCA1-deficient mice, Cell Growth Differ 10 (1999), 1-10.
30. C. Kuperwasser, G.D. Hurlbut, F.S. Kittrell, E.S. Dickinson, R. Laucirica, D. Medina, S.P. Naber and D.J. Jerry, Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome, The American Journal of Pathology 157 (2000), 2151-2159.
31. D.J. Jerry, F.S. Kittrell, C. Kuperwasser, R. Laucirica, E.S. Dickinson, P.J. Bonilla, J.S. Butel and D. Medina, A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development, Oncogene 19 (2000), 1052-1058.
32. D. Medina, F.S. Kittrell, J. Hill, A. Shepard, G. Thordarson and P. Brown, Tamoxifen inhibition of estrogen receptor-alpha-negative mouse mammary tumorigenesis, Cancer Research 65 (2005), 3493-3496.
33. S.C. Lin, K.F. Lee, A.Y. Nikitin, S.G. Hilsenbeck, R.D. Cardiff, A. Li, K.W. Kang, S.A. Frank, W.H. Lee and E.Y. Lee, Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis, Cancer Research 64 (2004), 3525-3532.
34. B. Li, K.L. Murphy, R. Laucirica, F. Kittrell, D. Medina and J.M. Rosen, A transgenic mouse model for mammary carcino-genesis, Oncogene 16 (1998), 997-1007.
35. B. Li, N. Greenberg, L.C. Stephens, R. Meyn, D. Medina and J.M. Rosen, Preferential overexpression of a 172Arg → Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development, Cell Growth Differ 5 (1994), 711-721.
36. S.W. Wijnhoven, E. Zwart, E.N. Speksnijder, R.B. Beems, K.P. Olive, D.A. Tuveson, J. Jonkers, M.M. Schaap, J. van den Berg, T. Jacks, H. van Steeg and A. de Vries, Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development, Cancer Research 65(2005), 8166-8173.
37. L.A. Donehower, L.A. Godley, C.M. Aldaz, R. Pyle, Y.P. Shi, D. Pinkel, J. Gray, A. Bradley, D. Medina and H.E. Varmus, Deficiency ofp53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability, Genes & Development 9 (1995), 882-895.
38. D. Medina, F.S. Kittrell, A. Shepard, A. Contreras, J.M. Rosen and J. Lydon, Hormone dependence in premalignant mammary progression, Cancer Research 63 (2003), 1067-1072.
39. N. Chester, H. Babbe, J. Pinkas, C. Manning and P. Leder, Mutation of the murine Bloom's syndrome gene produces global genome destabilization, Molecular and Cellular Biology 26 (2006), 6713-6726.
40. L.D. McDaniel, N. Chester, M. Watson, A.D. Borowsky, P. Leder and R.A. Schultz, Chromosome instability and tumor predisposition inversely correlate with BLM protein levels, DNA Repair 2 (2003), 1387-1404.
41. M.E. Moynahan, The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans, Oncogene 21(2002), 8994-9007.
42. A. McCarthy, K. Savage, A. Gabriel, C. Naceur, J.S. Reis-Filho and A. Ashworth, A mouse model of basal-like breast carcinoma with metaplastic elements, The Journal of pathology 211 (2007), 389-398.
43. A.J. Poole, Y. Li, Y. Kim, S.C. Lin, W.H. Lee and E.Y. Lee, Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist, Science (New York, NY 314 (2006), 1467-1470.
44. W. Li, C. Xiao, B.K. Vonderhaar and C.X. Deng, A role of estrogen/ ERalpha signaling in BRCA1-associated tissue-specific tumor formation, Oncogene (2007).
45. L.P. Jones, M.T. Tilli, S. Assefnia, K. Torre, F.D. Halama, A. Parrish, E.M. Rosen and P.A. Furth, Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer, Oncogene (2007).
46. J. Jonkers, R. Meuwissen, H. van der Gulden, H. Peterse, M. van der Valk and A. Berns, Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer, Nature Genetics 29 (2001), 418-425.
47. A.L. Bane, J.C. Beck, I. Bleiweiss, S.S. Buys, E. Catalano, M.B. Daly, G. Giles, A.K. Godwin, H. Hibshoosh, J.L. Hopper, E.M. John, L. Layfield, T. Longacre, A. Miron, R. Senie, M.C. Southey, D.W. West, A.S. Whittemore, H. Wu, I.L. Andrulis and F.P. O'Malley, BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays, The American Journal of Surgical Pathology 31 (2007), 121-128.
48. P.W. Derksen, X. Liu, F. Saridin, H. van der Gulden, J. Zevenhoven, B. Evers, J.R. van Beijnum, A.W. Griffioen, J. Vink, P. Krimpenfort, J.L. Peterse, R.D. Cardiff, A. Berns and J. Jonkers, Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell 10 (2006), 437-449.
49. J.V. Alvarez, D. Perez and L.A. Chodosh, mILC-ing the mouse mammary gland: A model for invasive lobular carcinoma, Cancer Cell 10 (2006), 347-349.
50. R.D. Cardiff, Validity of mouse mammary tumour models for human breast cancer: Comparative pathology, Microscopy Research and Technique 52 (2001), 224-230.
51. F. Xu, H. Sahni, S. Settnek, A. Gupta, J. Phillips, D. Zhang, J. Beasley, S. De Coronado, U. Wagner, K. Rosso, K. Malone, D. Singer, C. Marks, B. Tarnowski and K. Buetow, Mouse models of human cancer web-based resources, AMIA Annual Symposium Proceedings/AMIA Symposium (2003), 1056.